Ferreira, Anderson J <br/><br/>
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.  [electronic resource] 

 -  Experimental physiology  Mar 2011 
 - 287-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-445X 
<br/><br/><label>Standard No.: </label>10.1113/expphysiol.2010.055277  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin I--biosynthesis<br/>Angiotensin-Converting Enzyme 2<br/>Animals<br/>Cell Culture Techniques<br/>Collagen--metabolism<br/>Enzyme Activation--drug effects<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Fibroblasts--metabolism<br/>Fibrosis--metabolism<br/>Heart--drug effects<br/>Hypertension--enzymology<br/>Male<br/>Myocardium--enzymology<br/>Peptide Fragments--biosynthesis<br/>Peptidyl-Dipeptidase A--biosynthesis<br/>Phosphorylation--drug effects<br/>Rats<br/>Rats, Inbred SHR<br/>Rats, Inbred WKY<br/>Receptor, Angiotensin, Type 1--metabolism<br/>Signal Transduction--drug effects<br/>Xanthones--pharmacology